- All Categories
- E-Services
Nahdi Global
Flash Sales
Nahdicare Health center
Product Description:
Oftalmolosa® Cusi Gentamicin 0.3%
Used for:
Infections of the anterior pole of the eye caused by germs sensitive to gentamicin; corneal ulcers and
corneal bacterial abscesses. Conjunctivitis. Keratitis. Staphyloccocia. Blepharitis. Dacryocystitis.
Preoperative sterilization of the conjunctiva.
How to use:
Normally two or three applications daily.
The number of daily applications and length of treatment can be modified in accordance with
physician’s criteria.
Paediatric population
Safety and effectiveness in the paediatric population have not been established.
Correct administration procedure:
Application to the inside of the eye:
Separate the eyelids from the eye and apply a small amount (approximately a grain of rice) of ointment
into the conjunctival sac.
Application to the outside of the eye:
Soften and remove crusts with warm water, and apply the product directly onto the affected area.
Application of the ointment should be carried out under hygienic conditions. Do not touch the tube tip
to any surface. Close tube after every application.
Method of administration:
• For ocular use only.
• To prevent contamination of the dropper tip and solutions, care must be taken not to touch the
eyelids, surrounding areas or other surfaces with the dropper tip of the bottle. Instruct patients to keep
the bottle tightly closed when not in use.
• If more than one topical ophthalmic product is being used, the products must be administered
at least 5 minutes apart. Eye ointments should be administered last.
Caution & Warnings:
Sensitivity to topically administered aminoglycosides may occur in some patients. Severity of
hypersensitivity reactions may vary from local effects to generalized reactions such as erythema, itching,
urticarial, skin rash, anaphylaxis, anaphylactoid reactions, or bullous reactions. If hypersensitivity
develops during use of this medicine, treatment should be discontinued. (See Section 4.8)
• Cross-hypersensitivity to other aminoglycosides can occur, and the possibility that patients who
become sensitized to topical gentamicin may also be sensitive to other topical and/or systemic
aminoglycosides should be considered.
• Serious adverse reactions including neurotoxicity, ototoxicity and nephrotoxicity have occurred
in patients receiving systemic aminoglycoside therapy or when applied topically to open wounds or
damaged skin. Although these effects have not been reported following topical ocular use of
gentamicin, caution is advised when used concomitantly.
• Prolonged use of OFTALMOLOSA® CUSÍ Gentamicin 0.3% may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be initiated
mg/g Ointment: 1 g ointment contains 5 mg gentamicin sulphate (equivalent to 3 mg gentamicin)
Product Details:
Product Description:
Oftalmolosa® Cusi Gentamicin 0.3%
Used for:
Infections of the anterior pole of the eye caused by germs sensitive to gentamicin; corneal ulcers and
corneal bacterial abscesses. Conjunctivitis. Keratitis. Staphyloccocia. Blepharitis. Dacryocystitis.
Preoperative sterilization of the conjunctiva.
How to use:
Normally two or three applications daily.
The number of daily applications and length of treatment can be modified in accordance with
physician’s criteria.
Paediatric population
Safety and effectiveness in the paediatric population have not been established.
Correct administration procedure:
Application to the inside of the eye:
Separate the eyelids from the eye and apply a small amount (approximately a grain of rice) of ointment
into the conjunctival sac.
Application to the outside of the eye:
Soften and remove crusts with warm water, and apply the product directly onto the affected area.
Application of the ointment should be carried out under hygienic conditions. Do not touch the tube tip
to any surface. Close tube after every application.
Method of administration:
• For ocular use only.
• To prevent contamination of the dropper tip and solutions, care must be taken not to touch the
eyelids, surrounding areas or other surfaces with the dropper tip of the bottle. Instruct patients to keep
the bottle tightly closed when not in use.
• If more than one topical ophthalmic product is being used, the products must be administered
at least 5 minutes apart. Eye ointments should be administered last.
Caution & Warnings:
Sensitivity to topically administered aminoglycosides may occur in some patients. Severity of
hypersensitivity reactions may vary from local effects to generalized reactions such as erythema, itching,
urticarial, skin rash, anaphylaxis, anaphylactoid reactions, or bullous reactions. If hypersensitivity
develops during use of this medicine, treatment should be discontinued. (See Section 4.8)
• Cross-hypersensitivity to other aminoglycosides can occur, and the possibility that patients who
become sensitized to topical gentamicin may also be sensitive to other topical and/or systemic
aminoglycosides should be considered.
• Serious adverse reactions including neurotoxicity, ototoxicity and nephrotoxicity have occurred
in patients receiving systemic aminoglycoside therapy or when applied topically to open wounds or
damaged skin. Although these effects have not been reported following topical ocular use of
gentamicin, caution is advised when used concomitantly.
• Prolonged use of OFTALMOLOSA® CUSÍ Gentamicin 0.3% may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be initiated
mg/g Ointment: 1 g ointment contains 5 mg gentamicin sulphate (equivalent to 3 mg gentamicin)
Product Details: